title: Anti-NMDA Receptor Encephalitis in Psychiatry.
abstract: Anti-NMDA receptor encephalitis is an autoimmune disorder in which antibodies attack NMDA (N-methyl-D-aspartate)-type glutamate receptors at central neuronal synapses. Symptoms include a highly characteristic set of neurologic deficits, but also prominent psychiatric manifestations that often bring mental health professionals into the course of care. Distinct phases of illness have become increasingly appreciated, and include a range of psychotic symptoms early in the course of the disease followed by more severe fluctuations in consciousness with neurologic involvement, and ultimately protracted cognitive and behavioral deficits. Young women are most commonly impacted and an ovarian teratoma is sometimes associated with the syndrome. Patients respond well to immunotherapy, but psychiatric symptoms can be challenging to manage. We provide an up to date review of this disorder and highlight the role of psychiatry in diagnosis, symptomatology, and treatment.
authors.affiliation: Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Kayser
authors.affiliation: Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Spain.
authors.forename: Josep
authors.initials: J
authors.lastname: Dalmau
keywords: NMDA receptor; autoimmune; paraneoplastic; schizophrenia; synapse
references.citation: Acta Neuropathol. 2002 May;103(5):509-15
references.pmid: 11935268
references.citation: Neurology. 2010 Sep 7;75(10):e44-6
references.pmid: 20819992
references.citation: Nat Neurosci. 2010 Jan;13(1):76-83
references.pmid: 19915563
references.citation: Am J Psychiatry. 2011 Mar;168(3):245-51
references.pmid: 21368306
references.citation: Neurology. 2008 Feb 12;70(7):504-11
references.pmid: 17898324
references.citation: Neurology. 2010 Nov 9;75(19):1735-9
references.pmid: 21060097
references.citation: J Neurol. 2011 Apr;258(4):686-8
references.pmid: 20972895
references.citation: Neurology. 1998 Oct;51(4):1146-50
references.pmid: 9781545
references.citation: Lancet Neurol. 2008 Apr;7(4):327-40
references.pmid: 18339348
references.citation: Ann Neurol. 2009 Jul;66(1):11-8
references.pmid: 19670433
references.citation: Nat Clin Pract Neurol. 2007 May;3(5):291-6
references.pmid: 17479076
references.citation: Lancet. 2011 Jul 2;378(9785):98
references.pmid: 21724038
references.citation: J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):90-7
references.pmid: 21304144
references.citation: Arch Neurol. 2009 Apr;66(4):458-64
references.pmid: 19364930
references.citation: Am J Psychiatry. 1991 Oct;148(10):1301-8
references.pmid: 1654746
references.citation: Am J Psychiatry. 2010 Sep;167(9):1039-50
references.pmid: 20439389
references.citation: Neurology. 2011 Feb 15;76(7 Suppl 2):S64-6
references.pmid: 21321356
references.citation: Brain. 2010 Jun;133(Pt 6):1655-67
references.pmid: 20511282
references.citation: J ECT. 2006 Dec;22(4):267-70
references.pmid: 17143159
references.citation: Lancet Neurol. 2011 Jan;10(1):63-74
references.pmid: 21163445
references.citation: Ann Neurol. 2007 Jan;61(1):25-36
references.pmid: 17262855
references.citation: Lancet Neurol. 2010 Aug;9(8):776-85
references.pmid: 20580615
references.citation: Eur J Neurosci. 2010 Jul;32(2):298-309
references.pmid: 20646055
references.citation: J Psychiatr Res. 1999 Nov-Dec;33(6):523-33
references.pmid: 10628529
references.citation: J Neurosci. 2010 Apr 28;30(17):5866-75
references.pmid: 20427647
references.citation: Lancet Neurol. 2008 Dec;7(12):1091-8
references.pmid: 18851928
references.citation: Biol Psychiatry. 2009 Sep 15;66(6):e13-4
references.pmid: 19539270
references.citation: Ann Neurol. 2009 Apr;65(4):424-34
references.pmid: 19338055
references.citation: Hippocampus. 2008;18(2):125-34
references.pmid: 17924525